EMA Highlights: First-in-class treatment to lower cholesterol
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Patients whose high cholesterol cannot be controlled by currently available therapies are set to have a new treatment option.
by Gary Finnegan: Survival rates in young patients with high-risk neuroblastoma can be improved by Unituxin (dinutuximab), a new treatment approved by the European Medicines Agency (EMA).
by Gary Finnegan: Canada could save $7.3 billion annually with universal public coverage of medically necessary prescription drugs, according to new research from the University of British Columbia… read more.
by Gary Finnegan: Egg consumption may reduce the risk of type 2 diabetes, according to new research from the University of Eastern Finland which draws on a long-term… read more.
by Gary Finnegan: China is facing a major increasing in osteoporosis-related fractures, according to a new study which forecasts a doubling of fractures in the next 20 years.
by Gary Finnegan: Health outcomes for children conceived using assisted reproduction technologies (ART) have improved significantly over the past two decades, according to a Danish-led study. However, the… read more.
by Gary Finnegan: Five new medicines have been recommended for approval at the latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use
by Gary Finnegan: The European Medicines Agency (EMA) has reduced the fees it charges to companies who hold – or apply for – marketing authorisation for medicines.
by Gary Finnegan: Medicines watchdogs on both sides of the Atlantic could significantly step up collaboration if a new transatlantic trade deal is sewn up later this year.
by Gary Finnegan: Researchers in Canada have found that the chance having a heart attack or stroke increases significantly if a patient has been hospitalised for pneumonia –… read more.
by Gary Finnegan: Could years of diabetes research have been in vain? That is the question occupying scientists after the publication of a new study by researchers in… read more.
by Gary Finnegan: One of the commonly circulating forms of the flu virus, which is particularly common among children, could be eliminated, according to researchers at the Duke-NUS… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
